Chalfont, PA, United States of America

Mahesh Kumar Pallerla

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Arbutus Biopharma Corporation. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mahesh Kumar Pallerla. Retrieved from https://idiyas.com/inventor/mahesh-kumar-pallerla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mahesh Kumar Pallerla: Innovator in Pharmaceutical Chemistry

Introduction

Mahesh Kumar Pallerla is a notable inventor based in Chalfont, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for treating viral infections.

Latest Patents

Pallerla holds a patent titled "Methods for preparing substituted pyridinone-containing tricyclic compounds." This patent describes novel, scalable methods for synthesizing substituted tricyclic compounds that are useful in treating and preventing HBV and HBV-HDV infections and related conditions in subjects. He has 1 patent to his name.

Career Highlights

Mahesh Kumar Pallerla is currently employed at Arbutus Biopharma Corporation, where he continues to advance his research in pharmaceutical innovations. His work focuses on developing effective treatments for viral infections, contributing to the broader field of medicine.

Collaborations

Pallerla collaborates with esteemed colleagues, including Shuai Chen and Bruce D Dorsey, to further enhance the impact of his research and innovations.

Conclusion

Mahesh Kumar Pallerla is a dedicated inventor whose work in pharmaceutical chemistry is paving the way for new treatments for viral infections. His innovative methods and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…